Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
08/1998
08/11/1998US5792453 Transfecting cells in coronary arteries by injection of a transgene-inserted replication-deficit adenovirus; antiischemic agents; cardiotonic agents; vascular disease
08/07/1998CA2222987A1 Novel compounds
08/07/1998CA2222984A1 Novel rat
08/07/1998CA2222978A1 Novel compounds
08/07/1998CA2222961A1 Novel compounds
08/07/1998CA2222957A1 Novel histidine kinase
08/06/1998WO1998034121A2 Isolated p27 protein and methods for its production and use
08/06/1998WO1998034120A1 Protein fragment complementation assays to detect biomolecular interactions
08/06/1998WO1998033932A1 Lipid emulsions as gene transfection agents and method of preparing said emulsions
08/06/1998WO1998033929A2 Use of a polypeptide as cell receptor for adenoviruses
08/06/1998WO1998033925A1 Glutrnagln amidotransferase - a novel essential translational component
08/06/1998WO1998033916A2 Secreted proteins and polynucleotides encoding them
08/06/1998WO1998033914A1 Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response
08/06/1998WO1998033907A1 A tumor suppressor designated ts10q23.3
08/06/1998WO1998033904A2 An antisense oligonucleotide preparation method
08/06/1998WO1998033890A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use
08/06/1998WO1998033529A1 Treatment for urinary incontinence using gene therapy techniques
08/06/1998WO1998033527A2 Cancer immunotherapy with semi-allogeneic cells
08/06/1998WO1998033513A1 Soluble ctla4 mutant molecules and uses thereof
08/06/1998WO1998033478A2 Rna- and dna-based active agents in nanoparticles
08/06/1998WO1998033387A1 Tolerance to natural antibody antigens
08/06/1998WO1998022587A3 Pituitary-tumor-transforming-genes, and related products
08/06/1998WO1998017317A3 Process for producing biologically active polymer nanoparticle-nucleic acid conjugates
08/06/1998CA2279577A1 Treatment for urinary incontinence using gene therapy techniques
08/06/1998CA2279547A1 Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response
08/06/1998CA2279542A1 Tolerance to natural antibody antigens
08/06/1998CA2279490A1 Glutrnagln amidotransferase - a novel essential translational component
08/06/1998CA2279459A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use
08/06/1998CA2278931A1 Cysteine-depleted peptides recognized by a3-restricted cytotoxic lymphocytes, and uses therefor
08/06/1998CA2278849A1 A tumor suppressor designated ts10q23.3
08/06/1998CA2278771A1 Soluble ctla4 mutant molecules and uses thereof
08/06/1998CA2278678A1 Cancer immunotherapy with semi-allogeneic cells
08/06/1998CA2278595A1 Secreted proteins and polynucleotides encoding them
08/06/1998CA2251036A1 Use of a polypeptide as cell receptor for adenoviruses
08/06/1998CA2222981A1 Promoter of the human endoglin gene and its use
08/05/1998EP0856585A1 A conditional replication and expression system
08/05/1998EP0856579A1 An antisense oligonucleotide preparation method
08/05/1998EP0856062A2 Herpesvirus vectors and their uses
08/05/1998EP0856061A1 Materials and methods relating to the transfer of nucleic acid into quiescent cells
08/05/1998EP0856058A1 Cell-cycle checkpoint genes
08/05/1998EP0856051A1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof
08/05/1998EP0856050A1 Transforming growth factor alpha hi
08/05/1998EP0856006A1 Cytostatin ii
08/05/1998EP0856005A1 The aiolos gene
08/05/1998EP0855919A1 Hormone immunomodulated induction of mucosal immune responses
08/05/1998EP0722452A4 Nf-at polypeptides and polynucleotides
08/05/1998CN1189857A Recombinant MVA virus, and the use thereof
08/05/1998CA2221687A1 Tumor necrosis related receptor, tr5
08/04/1998US5789573 Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2
08/04/1998US5789568 Genetic engineering
08/04/1998US5789565 Serine threonine kinase receptor, ALK-7
08/04/1998US5789550 TRAF inhibitors
08/04/1998US5789543 Vertebrate embryonic pattern-inducing proteins and uses related thereto
08/04/1998US5789248 CAPL-specific oligonucleotides and method of inhibiting metastatic cancer
08/04/1998US5789245 Genetic engineering
08/04/1998US5789244 Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems
08/04/1998US5789229 Stranded RNA virus particles
08/04/1998US5789223 Human galactokinase gene
08/04/1998US5789218 DNA encoding valyl tRNA synthetase from Staphylococcus aureus
08/04/1998US5789217 Protection against bacterial infections
08/04/1998US5789200 Polypeptides and dna(rna) codes by genetic engineering for diagnosis and treatment of cancer, prostate, breast, lung or epithelial tumors
08/04/1998US5789194 Parasitic helminth venom allergen antigen 5-like genes and proteins
08/04/1998US5789187 Identification of differentiation factor receptors which inhibit the tumorigenicity of neuroblastoma cells in a ligand-independent manner
08/04/1998US5788970 Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
08/04/1998CA2047090C Genetic mechanisms of tumor suppression
08/03/1998CA2220852A1 Tumor necrosis related receptor, tr4
07/1998
07/31/1998CA2196496A1 Protein fragment complementation assay for the detection of protein-protein interactions
07/30/1998WO1998033067A1 Transcription factors that repress hiv transcription and methods based thereon
07/30/1998WO1998032870A1 A conditional replication and expression system
07/30/1998WO1998032869A1 Expression vectors and methods for in vivo expression of therapeutic polypeptides
07/30/1998WO1998032859A1 Multiple site delivery of adenoviral vector for the induction of angiogenesis
07/30/1998WO1998032853A2 Secreted proteins and polynucleotides encoding them
07/30/1998WO1998032849A2 Polynucleotide associated with the bo or bor syndrome, its corresponding polypeptide and diagnostic and therapeutic applications
07/30/1998WO1998032846A2 Enzymatic nucleic acid treatment of diseases or conditions related to levels of c-fos
07/30/1998WO1998032842A1 Adenoviruses having altered hexon proteins
07/30/1998WO1998032462A1 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination
07/30/1998WO1998032460A1 Methods for diagnosing and treating body weight related disorders in animals
07/30/1998WO1998032457A2 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
07/30/1998WO1998032456A1 Identification of broadly reactive dr restricted epitopes
07/30/1998WO1998022507A3 Receptor tyrosine kinase genes
07/30/1998WO1998019709A3 Cationic reagents for transfection
07/30/1998CA2456777A1 Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
07/30/1998CA2278770A1 Secreted proteins and polynucleotides encoding them
07/30/1998CA2278737A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
07/30/1998CA2278621A1 Multiple site delivery of adenoviral vector for the induction of angiogenesis
07/30/1998CA2278594A1 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination
07/30/1998CA2278341A1 A conditional replication and expression system
07/30/1998CA2278296A1 Identification of broadly reactive dr restricted epitopes
07/30/1998CA2276691A1 Methods for diagnosing and treating body weight related disorders in animals
07/29/1998EP0855444A2 Aspartic proteinase 2 (ASP2)
07/29/1998EP0855443A2 cDNA clone HE8CH90 that encodes a 7-transmembrane receptor
07/29/1998EP0855404A1 Interleukin-1 receptor antagonist beta (il-1rabeta)
07/29/1998EP0855185A2 Host-vector system for use in gene therapy
07/29/1998EP0855184A1 Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
07/29/1998EP0854930A1 Pharmaceutical composition useful for nucleic acid transfection, and use thereof
07/29/1998EP0854929A1 Recombinant viruses incorporating a protease cleavable protein
07/29/1998EP0854928A2 Multi-functional hematopoietic receptor agonists
07/29/1998EP0854922A1 Improvements in or relating to protection against intracellular infection
07/29/1998EP0854921A1 GENE THERAPY WITH MODIFIED p65 PROTEINS
07/29/1998EP0854918A1 Cells expressing both human cd4 and cxcr4
1 ... 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 ... 870